Elytra Biomaterials develops sustainable, biocompatible layers for bioelectronics, prosthetics, and invasive implants, enhancing integration with the human body and improving safety and functionality. By utilizing machine learning to optimize material properties, the company addresses the need for effective biological signal detection and tissue regeneration in medical applications.
Funding
Funding not disclosed
Founders
Product
Problem
Current bioelectronic interfaces, prosthetics, and invasive implants often lack optimal integration with the human body, leading to biocompatibility issues, reduced signal detection efficiency, and potential adverse reactions. Effective tissue regeneration and controlled substance release in medical applications also remain significant challenges.
Solution
Elytra Biomaterials develops sustainable, high-performance biomaterials designed to enhance the functionality and safety of bioelectronics, prosthetics, and invasive implants. The company creates biocompatible layers that facilitate improved integration with the human body, optimizing biological signal detection and reducing adverse reactions. Elytra also leverages chitosan-based materials to accelerate wound healing and promote tissue regeneration in both medical and cosmetic applications. Furthermore, they offer micro-encapsulation technologies for controlled release systems, operating under specific conditions of pH, temperature, and time, suitable for the food and pharmaceutical industries.
Target Audience
Elytra Biomaterials serves the bioelectronics, medical device, and pharmaceutical industries, including manufacturers of biosensors, prosthetics, invasive implants, and companies involved in wound care, tissue regeneration, and controlled substance delivery.
Features
- Conductive and biocompatible layers for enhanced biosensor integration and biological signal detection
- Biocompatible layers designed to improve the connection between prosthetics and the human body
- Protective layers for invasive medical implants, increasing safety and effectiveness
- Chitosan-based products for accelerated wound healing and tissue regeneration
- Micro-encapsulation technology for controlled release of active compounds
- Fluid transmission layers for specialized applications in medical devices and bioelectronics
- Chitosan utilization for efficient and sustainable clarification processes in alcoholic beverage production